Patents by Inventor Mustoori Sairam

Mustoori Sairam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARATION OF PROTEIN OR PEPTIDE
    Publication number: 20190263880
    Abstract: The present application relates to a process for the preparation of peptides or proteins or derivatives thereof by expression of synthetic oligonucleotide encoding desired protein or peptide in prokaryotic cell as ubiquitin fusion construct.
    Type: Application
    Filed: July 25, 2017
    Publication date: August 29, 2019
    Inventors: Veluri JAGAN MOHAN REDDY, Mustoori SAIRAM, Yeruva SRINIVASULU REDDY, Barui TAPAS, Jyothishwaran JYOTHISHWARAN, Kanduri VENKATA SADA SIVA RAO, Furkhan TAJAMUL, Malolanarasimhan KRISHNAN, Narayanasamy Murugan RAVICHANDRAN, Kedari CHAITANYAKUMAR, Goud Vasker RAKESH, Desai SAHEJAD
  • Vaccine
    Patent number: 8241645
    Abstract: A typhoid vaccine using heat shock protein (Hsp) of Salmonella typhi and a method for the manufacture thereof. A composition comprising an effective amount of a complex of a Hsp, in part or whole, either alone or covalently or non-covalently bound to an antigenic molecule, which when administered to a mammal elicits specific immunological responses in the host. The antigenic molecule refers to the exogenous antigens/immunogens such as viz LPS, peptide, nucleic acid or polysaccharide or antigenic/immunogenic fragments and derivatives thereof.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: August 14, 2012
    Assignee: The Director General, Defence Research and Development Organisation
    Inventors: Mustoori Sairam, Anju Bansal, Sarada S. Surya Kumari, Piyush Paliwal
  • Vaccine
    Publication number: 20100196416
    Abstract: A typhoid vaccine using heat shock protein (Hsp) of Salmonella typhi and a method for the manufacture thereof. A method of administering a composition comprising an effective amount of a complex consisting of a Hsp, in part or whole, either alone or covalently or non-covalently bound to an antigenic molecule, which when administered elicits specific immunological responses in the host is also describe. The Antigenic molecule refers to the exogenous antigens/immunogens viz LPS, peptide, nucleic acid or polysaccharide or antigenic/immunogenic fragments and derivatives thereof.
    Type: Application
    Filed: October 4, 2006
    Publication date: August 5, 2010
    Inventors: Mustoori Sairam, Anju Bansal, Sarada S. Surya Kumari, Piyush Paliwal